Was told by James Campbell yesterday that data collection and submission remains on track by the March 31 deadline. And there will be no variation to this timeline re: convertible note agreement.
GDelaney, do you think you could post the link to the UBS report on Cephalon/Omapro if it is available? Thanks.
- Forums
- ASX - By Stock
- CXS
- promising biotech
promising biotech, page-5
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)